Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

Presentation SIF 2019

Closing a Hole in the Heart

Presenter: David G. Rizik

March 27, 2019

Presentation Cardiovascular Interventions 2018

PFO Closure to Prevent Recurrent Cryptogenic Stroke

Presenter: Matthew J. Price

October 26, 2018

Presentation ECHO 2018

ASE Guidelines: Assessment of PFO / ASD and Cardiac Source of Embolism

Presenter: Muhamed Sarić

April 18, 2018

Presentation Controversies and Advances 2017

PFO Closure - Close Them All?

Presenter: Saibal Kar

November 16, 2017

Presentation LAA 2017

PFO Case Reviews: To Close or Not to Close

Presenter: David E. Thaler

July 22, 2017

Presentation LAA 2017

Patient Selection and Outcomes of PFO Closure in Idiopathic Stroke: Lessons From RESPECT and Worldwide Registries

Presenter: David E. Thaler

July 22, 2017

Presentation LAA 2017

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

Presenter: M. Edip Gurol

July 21, 2017

Presentation

PFO Closure in the Gore REDUCE Clinical Trial

May 24, 2017

Presentation

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

May 24, 2017

Presentation SIF 2017

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Presenter: James A. Goldstein

March 09, 2017

Presentation TCT 2016

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler

November 01, 2016

Presentation

Device Closure of PFO After Stroke: Pooled Analysis of Completed Randomized Trials

Presenter: David M. Kent

February 22, 2016

Presentation

PFO Closure for Cryptogenic Stroke: To Close or Not To Close That Is Still The Question

Presenter: Pablo Rengifo

October 29, 2015

Presentation

Recurrent Cerebral Ischemia After PFO Closure in Older Patients

Presenter: Paolo Scacciatella

July 07, 2015

Presentation

PFO Closure Following Cryptogenic Stroke or TIA

Presenter: Mikaeil Mirzaali

July 02, 2015

Presentation

Cost-Effectiveness of PFO Closure vs Medical Therapy for Cryptogenic Stroke

Presenter: Christopher A. Pickett

September 30, 2014

Presentation TCT 2014

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Sanjay Kaul

September 13, 2014

Presentation TCT 2014

Dissecting the Evidence: Is There Anyone with Stroke Who Can Benefit from PFO Closure?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, John D. Carroll

September 13, 2014

Presentation TCT 2014

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler

September 13, 2014

Advertisement

Closing a Hole in the Heart

PFO Closure to Prevent Recurrent Cryptogenic Stroke

ASE Guidelines: Assessment of PFO / ASD and Cardiac Source of Embolism

PFO Closure - Close Them All?

PFO Case Reviews: To Close or Not to Close

Patient Selection and Outcomes of PFO Closure in Idiopathic Stroke: Lessons From RESPECT and Worldwide Registries

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

PFO Closure in the Gore REDUCE Clinical Trial

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Device Closure of PFO After Stroke: Pooled Analysis of Completed Randomized Trials

PFO Closure for Cryptogenic Stroke: To Close or Not To Close That Is Still The Question

Recurrent Cerebral Ischemia After PFO Closure in Older Patients

PFO Closure Following Cryptogenic Stroke or TIA

Cost-Effectiveness of PFO Closure vs Medical Therapy for Cryptogenic Stroke

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Dissecting the Evidence: Is There Anyone with Stroke Who Can Benefit from PFO Closure?

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content